|Bid||0.0350 x N/A|
|Ask||0.0400 x N/A|
|Day's Range||0.0350 - 0.0350|
|52 Week Range||0.0250 - 0.1950|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Calgary, AB – December 1, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises ...
Vancouver, BC / December 1, 2022 / Universal Ibogaine Inc. (the “Company”) (TSXV: IBO) is pleased to announce that it has closed its non-brokered private placement of convertible notes (the “Notes”...
Calgary, AB – TheNewswire - June 24, 2022 – Universal Ibogaine Inc. (TSXV:IBO), (OTC:IBOGF) and (FSE:JC4) (“UI” or the “Company”) a life sciences company with a mission to transform addiction treat...